BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1446 related articles for article (PubMed ID: 35422048)

  • 1. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
    Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
    World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel ferroptosis-related gene signature associated with cell cycle for prognosis prediction in patients with clear cell renal cell carcinoma.
    Chen S; Zhang E; Guo T; Shao J; Wang T; Zhang N; Wang X; Zheng J
    BMC Cancer; 2022 Jan; 22(1):1. PubMed ID: 34979993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of A Novel Ferroptosis-related Prognostic Risk Signature for Survival Prediction in Clear Cell Renal Cell Carcinoma Patients.
    Tang F; Zhang J; Zhu L; Lai Y; Li Z; Lu Z; Tang Z; Mai Y; Huang R; He Z
    Urol J; 2022 May; 19(4):289-299. PubMed ID: 35598038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of new prognostic signature based on ferroptosis-related genes in clear cell renal cell carcinoma.
    Zheng B; Niu Z; Si S; Zhao G; Wang J; Yao Z; Cheng F; He W
    Aging (Albany NY); 2021 Aug; 13(15):19789-19804. PubMed ID: 34370716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma.
    Hong Y; Lin M; Ou D; Huang Z; Shen P
    BMC Cancer; 2021 Jul; 21(1):831. PubMed ID: 34281531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma.
    Wu G; Wang Q; Xu Y; Li Q; Cheng L
    Aging (Albany NY); 2020 Jul; 12(14):14933-14948. PubMed ID: 32688345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma.
    Liu S; Yao Y; Hou M; Mei J; Sun L; Zhang G
    BMC Cancer; 2023 Nov; 23(1):1079. PubMed ID: 37940859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurate prognostic prediction for patients with clear cell renal cell carcinoma using a ferroptosis-related long non-coding RNA risk model.
    Xiang X; Guo Y; Chen Z; Zhang F; Qin Y
    Cancer Biomark; 2023; 37(2):95-107. PubMed ID: 37248883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N6‑methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma.
    Zheng Z; Mao S; Guo Y; Zhang W; Liu J; Li C; Yao X
    Oncol Rep; 2020 May; 43(5):1591-1605. PubMed ID: 32323803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of m6A-associated ferroptosis genes in renal clear cell carcinoma.
    Pang S; Zhao S; Dongye Y; Fan Y; Liu J
    Cell Biol Int; 2024 Jun; 48(6):777-794. PubMed ID: 38440906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomogram Based on microRNA Signature Contributes to Improve Survival Prediction of Clear Cell Renal Cell Carcinoma.
    Zhao E; Bai X
    Biomed Res Int; 2020; 2020():7434737. PubMed ID: 32280701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes.
    Diao X; Guo C; Liu L; Wang G; Li S
    Thorac Cancer; 2021 Dec; 12(23):3236-3247. PubMed ID: 34672420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma.
    Ju L; Shi Y; Liu G
    PeerJ; 2022; 10():e14506. PubMed ID: 36570012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and validation of a ferroptosis-related long noncoding RNA signature in clear cell renal cell carcinoma.
    Zhu Z; Zhang C; Qian J; Feng N; Zhu W; Wang Y; Gong Y; Li X; Lin J; Zhou L
    Cancer Cell Int; 2022 Sep; 22(1):283. PubMed ID: 36104748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients.
    Li H; Zhang X; Yi C; He Y; Chen X; Zhao W; Yu D
    BMC Cancer; 2021 Jul; 21(1):835. PubMed ID: 34284753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
    Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
    Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferroptosis-Related Long Noncoding RNA Signature Predicts Prognosis of Clear Cell Renal Carcinoma.
    Liu JW; Supandi F; Dhillon SK
    Folia Biol (Praha); 2022; 68(1):1-15. PubMed ID: 36201853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiles of overall survival-related gene expression-based risk signature and their prognostic implications in clear cell renal cell carcinoma.
    He Z; Deng T; Duan X; Zeng G
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32789468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide screening and cohorts validation identifying novel lncRNAs as prognostic biomarkers for clear cell renal cell carcinoma.
    Zhang C; Huang D; Liu A; Xu Y; Na R; Xu D
    J Cell Biochem; 2020 Mar; 121(3):2559-2570. PubMed ID: 31646670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New Prognostic Risk Signature of Eight Ferroptosis-Related Genes in the Clear Cell Renal Cell Carcinoma.
    Chen J; Zhan Y; Zhang R; Chen B; Huang J; Li C; Zhang W; Wang Y; Gao Y; Zheng J; Li Y
    Front Oncol; 2021; 11():700084. PubMed ID: 34249761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 73.